{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T23:07:05Z","timestamp":1771456025350,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jsat.2019.07.017","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T11:10:59Z","timestamp":1564139459000},"page":"51-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Factors impeding switching from methadone to buprenorphine in heroin users receiving methadone maintenance therapy - A naturalistic cohort study"],"prefix":"10.1016","volume":"105","author":[{"given":"Kuan-Shang","family":"Chung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5627-9969","authenticated-orcid":false,"given":"Hung-Chi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Yao","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Shi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dian-Jeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.jsat.2019.07.017_bb0005","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/QAI.0b013e318209751e","article-title":"HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine\/naloxone treatment within HIV clinical care settings: Results from a multisite study","volume":"56","author":"Altice","year":"2011","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"1","key":"10.1016\/j.jsat.2019.07.017_bb0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/ewjm.172.1.43","article-title":"Use of methadone","volume":"172","author":"Anderson","year":"2000","journal-title":"The Western Journal of Medicine"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2019.07.017_bb0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drugalcdep.2009.03.020","article-title":"Comparing overdose mortality associated with methadone and buprenorphine treatment","volume":"104","author":"Bell","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"7\u20138","key":"10.1016\/j.jsat.2019.07.017_bb0020","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0027-9684(15)30175-9","article-title":"Opioid addiction and abuse in primary care practice: A comparison of methadone and buprenorphine as treatment options","volume":"104","author":"Bonhomme","year":"2012","journal-title":"Journal of the National Medical Association"},{"issue":"1","key":"10.1016\/j.jsat.2019.07.017_bb0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0376-8716(03)00071-1","article-title":"Cessation of methadone maintenance treatment using buprenorphine: Transfer from methadone to buprenorphine and subsequent buprenorphine reductions","volume":"71","author":"Breen","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.jsat.2019.07.017_bb0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jsat.2005.11.007","article-title":"Slow tapering from methadone maintenance in a program encouraging indefinite maintenance","volume":"30","author":"Calsyn","year":"2006","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2019.07.017_bb0035","first-page":"34","article-title":"Infective endocarditis secondary to intravenous Subutex abuse","volume":"50","author":"Chong","year":"2009","journal-title":"Singapore Medical Journal"},{"key":"10.1016\/j.jsat.2019.07.017_bb0040","doi-asserted-by":"crossref","unstructured":"Connock, M., Juarez-Garcia, A., Jowett, S., Frew, E., Liu, Z., Taylor, R. J., . . . Taylor, R. S. (2007). Methadone and buprenorphine for the management of opioid dependence: A systematic review and economic evaluation. Health Technology Assessment, 11(9), 1\u2013171, (iii-iv).","DOI":"10.3310\/hta11090"},{"key":"10.1016\/j.jsat.2019.07.017_bb0045","series-title":"Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction","author":"CSAT","year":"2004"},{"issue":"8","key":"10.1016\/j.jsat.2019.07.017_bb0050","first-page":"871","article-title":"Buprenorphine\/naloxone versus methadone in opioid dependence: A longitudinal survey","volume":"15","author":"Curcio","year":"2011","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"5","key":"10.1016\/j.jsat.2019.07.017_bb0055","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/bja\/ael051","article-title":"Buprenorphine induces ceiling in respiratory depression but not in analgesia","volume":"96","author":"Dahan","year":"2006","journal-title":"British Journal of Anaesthesia"},{"issue":"10","key":"10.1016\/j.jsat.2019.07.017_bb0060","first-page":"599","article-title":"Treatment outcome predictors in flexible dose-duration methadone detoxification program","volume":"16","author":"Ekhtiari","year":"2013","journal-title":"Archives of Iranian Medicine"},{"key":"10.1016\/j.jsat.2019.07.017_bb0065","series-title":"European drug report","first-page":"96","author":"EMCDDA","year":"2018"},{"issue":"5","key":"10.1016\/j.jsat.2019.07.017_bb0070","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/ADM.0000000000000057","article-title":"Factors affecting noncompliance with buprenorphine maintenance treatment","volume":"8","author":"Fareed","year":"2014","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2019.07.017_bb0075","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.mlr.0000188913.50489.77","article-title":"Do mechanisms that link addiction treatment patients to primary care influence subsequent utilization of emergency and hospital care?","volume":"44","author":"Friedmann","year":"2006","journal-title":"Medical Care"},{"issue":"2","key":"10.1016\/j.jsat.2019.07.017_bb0080","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/bcp.12031","article-title":"Long term outcomes of pharmacological treatments for opioid dependence: Does methadone still lead the pack?","volume":"77","author":"Garcia-Portilla","year":"2014","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1016\/j.jsat.2019.07.017_bb0085","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000109982","article-title":"Influence of the dose on the severity of opiate withdrawal symptoms during methadone detoxification","volume":"81","author":"Glasper","year":"2008","journal-title":"Pharmacology"},{"issue":"2","key":"10.1016\/j.jsat.2019.07.017_bb0090","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/13556210500123126","article-title":"Induction of patients with moderately severe methadone dependence onto buprenorphine","volume":"10","author":"Glasper","year":"2005","journal-title":"Addiction Biology"},{"issue":"3","key":"10.1016\/j.jsat.2019.07.017_bb0095","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.drugalcdep.2005.01.023","article-title":"Reductions in criminal convictions after addiction treatment: 5-Year follow-up","volume":"79","author":"Gossop","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.jsat.2019.07.017_bb0100","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/add.12899","article-title":"Global statistics on addictive behaviours: 2014 status report","volume":"110","author":"Gowing","year":"2015","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.jsat.2019.07.017_bb0105","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00023210-200822020-00002","article-title":"Office-based maintenance treatment of opioid dependence: How does it compare with traditional approaches?","volume":"22","author":"Gunderson","year":"2008","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.jsat.2019.07.017_bb0110","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00213-010-1848-1","article-title":"Meta-analysis of the acute effects of nicotine and smoking on human performance","volume":"210","author":"Heishman","year":"2010","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.jsat.2019.07.017_bb0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/00952990902939719","article-title":"Pulmonary hypertension in first episode infective endocarditis among intravenous buprenorphine users: Case report","volume":"35","author":"Ho","year":"2009","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.jsat.2019.07.017_bb0120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12954-015-0075-9","article-title":"Impact of a methadone maintenance therapy pilot in Vietnam and its role in a scaled-up response","volume":"12","author":"Hoang","year":"2015","journal-title":"Harm Reduction Journal"},{"issue":"1","key":"10.1016\/j.jsat.2019.07.017_bb0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/add.12333","article-title":"Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial","volume":"109","author":"Hser","year":"2014","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.jsat.2019.07.017_bb0130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jfda.2014.01.019","article-title":"Analysis of drug abuse data reported by medical institutions in Taiwan from 2002 to 2011","volume":"22","author":"Hsu","year":"2014","journal-title":"Journal of Food and Drug Analysis"},{"issue":"2","key":"10.1016\/j.jsat.2019.07.017_bb0135","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0022-3565(24)29586-0","article-title":"Comparison of pharmacological activities of buprenorphine and norbuprenorphine: Norbuprenorphine is a potent opioid agonist","volume":"297","author":"Huang","year":"2001","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1016\/j.jsat.2019.07.017_bb0140","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/archpsyc.1991.01810250054007","article-title":"Symptoms of tobacco withdrawal. A replication and extension","volume":"48","author":"Hughes","year":"1991","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1016\/j.jsat.2019.07.017_bb0145","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0376-8716(94)90096-5","article-title":"Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine","volume":"36","author":"Janiri","year":"1994","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2019.07.017_bb0150","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/10550490500419094","article-title":"Transferring methadone-stabilized pregnant patients to buprenorphine using an immediate release morphine transition: An open-label exploratory study","volume":"15","author":"Jones","year":"2006","journal-title":"The American Journal on Addictions"},{"issue":"5","key":"10.1016\/j.jsat.2019.07.017_bb0155","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","article-title":"American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use","volume":"9","author":"Kampman","year":"2015","journal-title":"Journal of Addiction Medicine"},{"issue":"3","key":"10.1016\/j.jsat.2019.07.017_bb0160","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/ajad.12712","article-title":"Factors affecting the dose of methadone among patients receiving methadone maintenance therapy in Taiwan","volume":"27","author":"Li","year":"2018","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.jsat.2019.07.017_bb0165","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.2147\/NDT.S177370","article-title":"Predictors of sleep disturbance in heroin users receiving methadone maintenance therapy: A naturalistic study in Taiwan","volume":"14","author":"Li","year":"2018","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"6","key":"10.1016\/j.jsat.2019.07.017_bb0170","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/0009922819829038","article-title":"Buprenorphine overdose in young children: An underappreciated risk","volume":"58","author":"Lo Re","year":"2019","journal-title":"Clinical Pediatrics (Phila)"},{"issue":"4","key":"10.1016\/j.jsat.2019.07.017_bb0175","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/1570159043359477","article-title":"Buprenorphine: A unique drug with complex pharmacology","volume":"2","author":"Lutfy","year":"2004","journal-title":"Current Neuropharmacology"},{"issue":"2","key":"10.1016\/j.jsat.2019.07.017_bb0180","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0376-8716(00)00162-9","article-title":"The economic costs of heroin addiction in the United States","volume":"61","author":"Mark","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.jsat.2019.07.017_bb0185","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/syn.20355","article-title":"Differential regional effects of methadone maintenance compared to heroin dependence on mu-opioid receptor desensitization in rat brain","volume":"61","author":"Martin","year":"2007","journal-title":"Synapse"},{"key":"10.1016\/j.jsat.2019.07.017_bb0190","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"3","author":"Mattick","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2019.07.017_bb0195","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1016\/j.jsat.2019.07.017_bb0200","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s002130050804","article-title":"Buprenorphine and naloxone combinations: The effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers","volume":"141","author":"Mendelson","year":"1999","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.jsat.2019.07.017_bb0205","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jsat.2014.04.001","article-title":"Smoking cessation treatment among office-based buprenorphine treatment patients","volume":"47","author":"Nahvi","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2019.07.017_bb0210","first-page":"CD011117","article-title":"Opioid agonist treatment for pharmaceutical opioid dependent people","volume":"5","author":"Nielsen","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1016\/j.jsat.2019.07.017_bb0215","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/00003495-200969050-00006","article-title":"Buprenorphine\/naloxone: A review of its use in the treatment of opioid dependence","volume":"69","author":"Orman","year":"2009","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.jsat.2019.07.017_bb0220","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.drugalcdep.2009.07.013","article-title":"Long-term outcomes of office-based buprenorphine\/naloxone maintenance therapy","volume":"106","author":"Parran","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"issue":"2\u20133","key":"10.1016\/j.jsat.2019.07.017_bb0225","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.drugalcdep.2007.04.006","article-title":"Sublingual buprenorphine\/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone","volume":"90","author":"Rosado","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.jsat.2019.07.017_bb0230","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jsat.2009.05.003","article-title":"Buprenorphine maintenance treatment in a primary care setting: Outcomes at 1 year","volume":"37","author":"Soeffing","year":"2009","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.jsat.2019.07.017_bb0235","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s002130100920","article-title":"Blockade of hydromorphone effects by buprenorphine\/naloxone and buprenorphine","volume":"159","author":"Strain","year":"2002","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.jsat.2019.07.017_bb0240","first-page":"339","article-title":"Nutritional status of opiate-dependent persons before and during methadone maintenance therapy","volume":"61","author":"Szpanowska-Wohn","year":"2004","journal-title":"Przegla\u0327d Lekarski"},{"issue":"6","key":"10.1016\/j.jsat.2019.07.017_bb0245","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/add.12860","article-title":"Long-term mortality, remission, criminality and psychiatric comorbidity of heroin dependence: 11-Year findings from the Australian Treatment Outcome Study","volume":"110","author":"Teesson","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2019.07.017_bb0250","series-title":"World drug report 2016","first-page":"174","author":"United Nations Office on Drugs and Crime","year":"2016"},{"issue":"4","key":"10.1016\/j.jsat.2019.07.017_bb0255","first-page":"56","article-title":"Buprenorphine rescue from naltrexone-induced opioid withdrawal during relatively rapid detoxification from high-dose methadone: A novel approach","volume":"5","author":"Urban","year":"2008","journal-title":"Psychiatry (Edgmont)"},{"issue":"22","key":"10.1016\/j.jsat.2019.07.017_bb0260","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2014Tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2019.07.017_bb0265","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00213-007-0948-z","article-title":"Evaluation of the mu and kappa opioid actions of butorphanol in humans through differential naltrexone blockade","volume":"196","author":"Walsh","year":"2008","journal-title":"Psychopharmacology"},{"issue":"2 Suppl","key":"10.1016\/j.jsat.2019.07.017_bb0270","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0376-8716(03)00056-5","article-title":"The clinical pharmacology of buprenorphine: Extrapolating from the laboratory to the clinic","volume":"70","author":"Walsh","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2019.07.017_bb0275","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0022-3565(25)10510-7","article-title":"Acute administration of buprenorphine in humans: Partial agonist and blockade effects","volume":"274","author":"Walsh","year":"1995","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"5","key":"10.1016\/j.jsat.2019.07.017_bb0280","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: Ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1016\/j.jsat.2019.07.017_bb0285","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1477-7517-5-10","article-title":"The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients","volume":"5","author":"Wapf","year":"2008","journal-title":"Harm Reduction Journal"},{"issue":"7","key":"10.1016\/j.jsat.2019.07.017_bb0290","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.mppsy.2007.04.008","article-title":"Pharmacological treatment of addiction","volume":"6","author":"Watson","year":"2007","journal-title":"Psychiatry"},{"issue":"2","key":"10.1016\/j.jsat.2019.07.017_bb0295","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/clinchem\/37.2.205","article-title":"Methadone concentrations in plasma and their relationship to drug dosage","volume":"37","author":"Wolff","year":"1991","journal-title":"Clinical Chemistry"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547219300054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547219300054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:50:18Z","timestamp":1760039418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547219300054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":59,"alternative-id":["S0740547219300054"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2019.07.017","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors impeding switching from methadone to buprenorphine in heroin users receiving methadone maintenance therapy - A naturalistic cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2019.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}